U.S. Opioid Crisis: ‘A Lot Needs to be Done’ in 3 Key Areas

June 10, 2019

Robert Kramer, the CEO of Emergent Biosolutions, a biopharmaceutical company responsible for overdose reversal drug Naloxone, laid out three areas that require renewed attention. Read More >>

BHAP Logo

A National Trade Membership Association that provides education and advocacy for behavioral healthcare providers and related entities.
Login

Join Now

Subscribe Now

Contact Us

Address
1100 Glendon Ave
Suite 1500
Los Angeles, CA 90024
Tel 1-888-958-2282
Hours
Monday—Friday:
8:30AM–4:30PM